% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Peduzzi:182294,
author = {G. Peduzzi and L. Archibugi and V. Katzke$^*$ and M.
Gentiluomo and G. Capurso and A. C. Milanetto and M. Gazouli
and M. Goetz and H. Brenner$^*$ and R. C. H. Vermeulen and
R. Talar-Wojnarowska and G. Vanella and F. Tavano and M.
Lucchesi and B. Mohelnikova-Duchonova and X. Chen$^*$ and V.
Kiudelis and P. Hegyi and M. Oliverius and H. Stocker$^*$
and C. Stornello and L. Vodickova and P. Souček and J. P.
Neoptolemos and S. G. G. Testoni and L. Morelli and R. T.
Lawlor and D. Basso and J. R. Izbicki and S. Ermini and J.
Kupcinskas and R. Pezzilli and U. Boggi and H. W. M. van
Laarhoven and A. Szentesi and B. Erőss and G. Capretti and
B. Schöttker$^*$ and J. Skieceviciene and M. N. Aoki and C.
H. J. van Eijck and G. M. Cavestro and F. Canzian$^*$ and D.
Campa},
title = {{C}ommon variability in oestrogen-related genes and
pancreatic ductal adenocarcinoma risk in women},
journal = {Scientific reports},
volume = {12},
number = {1},
issn = {2045-2322},
address = {[London]},
publisher = {Macmillan Publishers Limited, part of Springer Nature},
reportid = {DKFZ-2022-02551},
pages = {18100},
year = {2022},
note = {#LA:C055#},
abstract = {The incidence of pancreatic ductal adenocarcinoma (PDAC) is
different among males and females. This disparity cannot be
fully explained by the difference in terms of exposure to
known risk factors; therefore, the lower incidence in women
could be attributed to sex-specific hormones. A two-phase
association study was conducted in 12,387 female subjects
(5436 PDAC cases and 6951 controls) to assess the effect on
risk of developing PDAC of single nucleotide polymorphisms
(SNPs) in 208 genes involved in oestrogen and pregnenolone
biosynthesis and oestrogen-mediated signalling. In the
discovery phase 14 polymorphisms showed a statistically
significant association (P < 0.05). In the replication none
of the findings were validated. In addition, a gene-based
analysis was performed on the 208 selected genes. Four genes
(NR5A2, MED1, NCOA2 and RUNX1) were associated with PDAC
risk, but only NR5A2 showed an association (P = 4.08 ×
10-5) below the Bonferroni-corrected threshold of
statistical significance. In conclusion, despite differences
in incidence between males and females, our study did not
identify an effect of common polymorphisms in the oestrogen
and pregnenolone pathways in relation to PDAC
susceptibility. However, we validated the previously
reported association between NR5A2 gene variants and PDAC
risk.},
cin = {C020 / C070 / C120 / C055 / HD01},
ddc = {600},
cid = {I:(DE-He78)C020-20160331 / I:(DE-He78)C070-20160331 /
I:(DE-He78)C120-20160331 / I:(DE-He78)C055-20160331 /
I:(DE-He78)HD01-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:36302831},
doi = {10.1038/s41598-022-22973-9},
url = {https://inrepo02.dkfz.de/record/182294},
}